CareDx Stock

CareDx FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of CareDx (CDNA) as of Aug 13, 2026 is -169.14 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 60.07 % — a change of -381.60% (lower).

FCF Conversion

-169.14 %

YoY

-381.60%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of CareDx is 2026 -169.14 % . FCF Conversion Rate (FCF/EBITDA) of CareDx was 2025 60.07 % . It decreases by -381.60% lower compared to the previous year.
Access this data via the Eulerpool API

CareDx Stock analysis

What does CareDx do? CareDx Inc is a US-based company specializing in diagnostic solutions for the transplantation industry. The company was founded in 1998 and is at the forefront of developing tests for transplant patients. CareDx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CareDx stock

FCF Conversion Rate (FCF/EBITDA) of CareDx is -169.14 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of CareDx changed from 60.07 % to -169.14 %, representing a -381.60% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) CareDx since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s CareDx with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — CareDx

All Key Metrics — CareDx